Thermo Fisher Scientific Inc. (TICKER: TMO) Benchmark And Performance Data

there are 12 of samples in the benchmark for Thermo Fisher Scientific Inc. in year 2022 in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 9 days for days sales outstanding in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 8 for cost of goods sold as a percent of revenue in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 7 for cash to cash cycle time in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 5 days for days of inventory in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 12 for sales growth in 2022. Thermo Fisher Scientific Inc. in its benchmark peer group, had rank 1 for gross revenue in 2022. Thermo Fisher Scientific Inc. headquarters region is East. Thermo Fisher Scientific Inc. has ticker symbol TMO. Thermo Fisher Scientific Inc. has the following profile: Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.. Thermo Fisher Scientific Inc. has primary indstury Diagnostics & Research. Thermo Fisher Scientific Inc. had a $$0 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had Revvity, Inc., and Danaher, and Thermo Fisher Scientific Inc., and Laboratory Corp. of America, and IQVIA Holdings, and Illumina, and Charles River Laboratories International, and Quest Diagnostics, and Agilent Technologies, and Mettler-Toledo International, and IDEXX Laboratories, and Waters benchmark peer companies for its SIC code in 2022. Thermo Fisher Scientific Inc. had 9.87% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 6.47% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 39 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 29 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 130,000 number of employees in 2022. Thermo Fisher Scientific Inc. had 12.12% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 10 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. had 0.10% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Thermo Fisher Scientific Inc. can reduce overall cost by $$5,776,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can reduce inventory with practices including SKU Reduction in 2022. Thermo Fisher Scientific Inc. can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Thermo Fisher Scientific Inc. can reduce inventory with practices including Forecast Accuracy in 2022. Thermo Fisher Scientific Inc. can reduce inventory with practices including Demand Shaping in 2022. Thermo Fisher Scientific Inc. can reduce days sales outstanding with practices including in 2022. Thermo Fisher Scientific Inc. can increase sales revenue by $$0 improving sales performance to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can increase revenue growth by $$46,000,000 by improving growth performance to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can increase overall revenue by $$46,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can increase days payables outstanding with practices including Strategic Sourcing in 2022. Thermo Fisher Scientific Inc. can increase days payables outstanding by $1,747,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can improve total financial performance by $$12,418,000,000 by improving revenue, costs, and working capital in 2022. Thermo Fisher Scientific Inc. can decrease overall working capital by $$6,596,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can decrease inventory days by $3,618,000,000 days by reducing inventory days to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can decrease days sales outstanding by $1,231,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Thermo Fisher Scientific Inc. can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Thermo Fisher Scientific Inc. can accelerate revenue growth practices including Pricing Optimization in 2022. Thermo Fisher Scientific Inc. can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. The total inventory for Thermo Fisher Scientific Inc. was $5,051,000,000.00 in 2021. The total inventory for Thermo Fisher Scientific Inc. was $4,029,000,000.00 in 2020. The total inventory for Thermo Fisher Scientific Inc. was $3,370,000,000.00 in 2019. The total inventory for Thermo Fisher Scientific Inc. was $3,005,000,000.00 in 2018. The total inventory for Thermo Fisher Scientific Inc. was $2,971,000,000.00 in 2017. The total inventory for Thermo Fisher Scientific Inc. was $2,213,000,000.00 in 2016. The total inventory for Thermo Fisher Scientific Inc. was $1,991,700,000.00 in 2015. The total inventory for Thermo Fisher Scientific Inc. was $1,859,500,000.00 in 2014. The total inventory for Thermo Fisher Scientific Inc. was $1,494,500,000.00 in 2013. The total inventory for Thermo Fisher Scientific Inc. was $1,443,300,000.00 in 2012. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $8,007,000,000.00 in 2021. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $6,930,000,000.00 in 2020. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $6,144,000,000.00 in 2019. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $6,057,000,000.00 in 2018. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $5,504,000,000.00 in 2017. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $4,971,000,000.00 in 2016. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $4,896,100,000.00 in 2014. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $4,612,000,000.00 in 2015. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $3,446,300,000.00 in 2013. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $3,354,900,000.00 in 2012. The sales, general, and administrative (SGA) for Thermo Fisher Scientific Inc. was $$8,993,000,000 in 2022. The revenue volatility for Thermo Fisher Scientific Inc. was 23.73% in 2022. The market capitalization for Thermo Fisher Scientific Inc. was $263,182,561,853.00 in 2014. The market capitalization for Thermo Fisher Scientific Inc. was $231,203,734,177.00 in 2015. The market capitalization for Thermo Fisher Scientific Inc. was $224,772,019,565.00 in 2013. The market capitalization for Thermo Fisher Scientific Inc. was $222,304,902,657.00 in 2019. The market capitalization for Thermo Fisher Scientific Inc. was $215,978,171,284.00 in 2018. The market capitalization for Thermo Fisher Scientific Inc. was $212,673,475,360.00 in 2016. The market capitalization for Thermo Fisher Scientific Inc. was $201,250,080,970.00 in 2020. The market capitalization for Thermo Fisher Scientific Inc. was $198,711,443,636.00 in 2017. The market capitalization for Thermo Fisher Scientific Inc. was $198,270,777,650.00 in 2012. The market capitalization for Thermo Fisher Scientific Inc. was $195,356,196,599.00 in 2021. The market capitalization for Thermo Fisher Scientific Inc. was $$207,949,000,000 in 2022. The gross revenue for Thermo Fisher Scientific Inc. was $39,211,000,000.00 in 2021. The gross revenue for Thermo Fisher Scientific Inc. was $32,218,000,000.00 in 2020. The gross revenue for Thermo Fisher Scientific Inc. was $25,542,000,000.00 in 2019. The gross revenue for Thermo Fisher Scientific Inc. was $24,358,000,000.00 in 2018. The gross revenue for Thermo Fisher Scientific Inc. was $20,918,000,000.00 in 2017. The gross revenue for Thermo Fisher Scientific Inc. was $18,274,000,000.00 in 2016. The gross revenue for Thermo Fisher Scientific Inc. was $16,965,000,000.00 in 2015. The gross revenue for Thermo Fisher Scientific Inc. was $16,889,600,000.00 in 2014. The gross revenue for Thermo Fisher Scientific Inc. was $13,090,300,000.00 in 2013. The gross revenue for Thermo Fisher Scientific Inc. was $12,509,900,000.00 in 2012. The gross revenue for Thermo Fisher Scientific Inc. was $$44,915,000,000 in 2022. The gross margin for Thermo Fisher Scientific Inc. was $18.94% in 2022. The days sales outstanding for Thermo Fisher Scientific Inc. was 65 days in 2022. The days payable outstanding for Thermo Fisher Scientific Inc. was 44 days in 2022. The days of inventory for Thermo Fisher Scientific Inc. was $75 in 2022. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was 57.76% in 2022. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $9,902,000,000.00 in 2016. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $9,397,600,000.00 in 2014. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $9,209,000,000.00 in 2015. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $7,561,200,000.00 in 2013. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $7,214,400,000.00 in 2012. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $19,573,000,000.00 in 2021. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $16,214,000,000.00 in 2020. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $14,214,000,000.00 in 2019. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $13,501,000,000.00 in 2018. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $11,470,000,000.00 in 2017. The cost of goods sold (COGS) for Thermo Fisher Scientific Inc. was $$25,944,000,000 in 2022. The cash to cash cycle time for Thermo Fisher Scientific Inc. was 96 in 2022. The annual percentage growth rate of Thermo Fisher Scientific Inc. was -0.15% in 2022. 96 days was the measured parity or middle performance level for cash to cash cycle time in Thermo Fisher Scientific Inc.'s peer group in 2022. 86 days was the measured parity or middle performance level for days of inventory in Thermo Fisher Scientific Inc.'s peer group in 2022. 57 days was the measured advantage or top third performance level for cash to cash cycle time in Thermo Fisher Scientific Inc.'s peer group in 2022. 55 days was the measured parity or middle performance level for days sales outstanding in Thermo Fisher Scientific Inc.'s peer group in 2022. 50 days was the measured advantage or top third performance level for days sales outstanding in Thermo Fisher Scientific Inc.'s peer group in 2022. 46 days was the measured advantage or top third performance level for days of inventory in Thermo Fisher Scientific Inc.'s peer group in 2022. 45.64% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Thermo Fisher Scientific Inc.'s peer group in 2022. 43 days was the measured superior or top ten performance level for days sales outstanding in Thermo Fisher Scientific Inc.'s peer group in 2022. 41 days was the measured superior or top ten performance level for cash to cash cycle time in Thermo Fisher Scientific Inc.'s peer group in 2022. 40.67% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Thermo Fisher Scientific Inc.'s peer group in 2022. 39.80% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Thermo Fisher Scientific Inc.'s peer group in 2022. 28.62% was the measured superior or top ten performance level for gross margin in Thermo Fisher Scientific Inc.'s peer group in 2022. 13.85% was the measured parity or middle performance level for sales volatility in Thermo Fisher Scientific Inc.'s peer group in 2022. 13.30% was the measured advantage or top third performance level for sales volatility in Thermo Fisher Scientific Inc.'s peer group in 2022. 11.86% was the measured superior or top ten performance level for sales volatility in Thermo Fisher Scientific Inc.'s peer group in 2022. 11 days was the measured superior or top ten performance level for days of inventory in Thermo Fisher Scientific Inc.'s peer group in 2022. 0.08% was the measured superior or top ten performance level for sales growth in Thermo Fisher Scientific Inc.'s peer group in 2022. -0.04% was the measured parity or middle performance level for sales growth in Thermo Fisher Scientific Inc.'s peer group in 2022. -0.00% was the measured advantage or top third performance level for sales growth in Thermo Fisher Scientific Inc.'s peer group in 2022. $25.41% was the measured advantage or top third performance level for gross margin in Thermo Fisher Scientific Inc.'s peer group in 2022. $19.35% was the measured parity or middle performance level for gross margin in Thermo Fisher Scientific Inc.'s peer group in 2022. $$5,708,000,000 was the measured parity or middle performance level for gross revenue in Thermo Fisher Scientific Inc.'s peer group in 2022. $$29,812,000,000 was the measured superior or top ten performance level for gross revenue in Thermo Fisher Scientific Inc.'s peer group in 2022. $$13,052,000,000 was the measured advantage or top third performance level for gross revenue in Thermo Fisher Scientific Inc.'s peer group.